• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol . Optimized respiratory virus influenza A whole genome sequencing strategies for improving even read coverage of segments

tetano

Editor, Senior Moderator
J Clin Virol


. 2025 Dec 3:182:105904.
doi: 10.1016/j.jcv.2025.105904. Online ahead of print. Optimized respiratory virus influenza A whole genome sequencing strategies for improving even read coverage of segments

Ruimin Gao[SUP] 1 [/SUP], Kennedy Irvine[SUP] 2 [/SUP], Cody Buchanan[SUP] 2 [/SUP], Cole Slater[SUP] 2 [/SUP], Nikki Pl Toledo[SUP] 2 [/SUP], Jianjun Jia[SUP] 2 [/SUP], Ameet Bharaj[SUP] 2 [/SUP], Brittany Lagasse[SUP] 2 [/SUP], April Powell[SUP] 2 [/SUP], Nathalie Bastien[SUP] 3 [/SUP]



Affiliations
Abstract

Whole genome sequencing is increasingly being deployed to support respiratory virus influenza clinical studies and surveillance. However, PCR amplification inefficiency results in an imbalanced distribution among the eight segments, which makes it challenging to obtain complete genomes. The difficulties of amplifying the longer polymerase genes, particularly when the cycle threshold (Ct) of a specimen is greater than 25, were highlighted by the whole genome sequencing (WGS) data of 109 influenza A virus (IAV) specimens. We addressed the low genome coverage of the PB1 segment by incorporating additional singleplex PB1 primers into the WGS PCR assay, as well as balancing the ratio of forward primer variants targeting a single nucleotide polymorphism - either uracil (U) or cytosine (C) - located at the 4th position of the promoter region at the 3' terminus. Furthermore, we have verified the improved performance of the Invitrogen™ UniPrime™ enzyme when compared to its predecessor, SuperScript IV™, and developed a more efficient thermal cycling condition ("C") to generate eight complete IAV segments. Lastly, we determined that the optimal amplicon-to-bead volume ratio for removal of shorter, unwanted DNA fragments during PCR amplicon purification is 1:0.5. In summary, these optimizations improve the recovery of lower coverage segments and provide strategies aimed at obtaining high quality IAV genomes by means of Oxford Nanopore Technologies-based sequencing, ultimately providing valuable insights for better serving influenza clinical research and surveillance.

Keywords: Bead ratio; Influenza A virus (IAV); Oxford Nanopore Technologies (ONT); PCR; Segment; Surveillance; WGS.

 
Back
Top